BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24549990)

  • 1. Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells.
    Kuchař M; Vaňková L; Petroková H; Cerný J; Osička R; Pelák O; Sípová H; Schneider B; Homola J; Sebo P; Kalina T; Malý P
    Proteins; 2014 Jun; 82(6):975-89. PubMed ID: 24549990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.
    Křížová L; Kuchař M; Petroková H; Osička R; Hlavničková M; Pelák O; Černý J; Kalina T; Malý P
    Autoimmunity; 2017 Mar; 50(2):102-113. PubMed ID: 28100093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered
    Plavec TV; Kuchař M; Benko A; Lišková V; Černý J; Berlec A; Malý P
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31137908
    [No Abstract]   [Full Text] [Related]  

  • 4. ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.
    Hlavničková M; Kuchař M; Osička R; Vaňková L; Petroková H; Malý M; Černý J; Arenberger P; Malý P
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
    Quiniou C; Domínguez-Punaro M; Cloutier F; Erfani A; Ennaciri J; Sivanesan D; Sanchez M; Chognard G; Hou X; Rivera JC; Beauchamp C; Charron G; Vilquin M; Kuchroo V; Michnick S; Rioux JD; Lesage S; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1216-30. PubMed ID: 25354400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
    Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
    Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III.
    Schröder J; Moll JM; Baran P; Grötzinger J; Scheller J; Floss DM
    J Biol Chem; 2015 Jan; 290(1):359-70. PubMed ID: 25371211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.
    Škrlec K; Zadravec P; Hlavničková M; Kuchař M; Vaňková L; Petroková H; Křížová L; Černý J; Berlec A; Malý P
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29966384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.
    Floss DM; Mrotzek S; Klöcker T; Schröder J; Grötzinger J; Rose-John S; Scheller J
    J Biol Chem; 2013 Jul; 288(27):19386-400. PubMed ID: 23673666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.
    Parham C; Chirica M; Timans J; Vaisberg E; Travis M; Cheung J; Pflanz S; Zhang R; Singh KP; Vega F; To W; Wagner J; O'Farrell AM; McClanahan T; Zurawski S; Hannum C; Gorman D; Rennick DM; Kastelein RA; de Waal Malefyt R; Moore KW
    J Immunol; 2002 Jun; 168(11):5699-708. PubMed ID: 12023369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells.
    Zhang XY; Zhang HJ; Zhang Y; Fu YJ; He J; Zhu LP; Wang SH; Liu L
    Immunogenetics; 2006 Jan; 57(12):934-43. PubMed ID: 16372191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
    Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
    Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy.
    Pan Y; Wang M; Chen X; Chen Y; Ai S; Wang M; Su W; Liang D
    Int Immunopharmacol; 2021 Feb; 91():107300. PubMed ID: 33383445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells.
    Wines BD; Yap ML; Powell MS; Tan PS; Ko KK; Orlowski E; Hogarth PM
    Immunol Cell Biol; 2017 Mar; 95(3):272-279. PubMed ID: 27645493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel high-affinity binders of human interferon gamma derived from albumin-binding domain of protein G.
    Ahmad JN; Li J; Biedermannová L; Kuchař M; Sípová H; Semerádtová A; Cerný J; Petroková H; Mikulecký P; Polínek J; Staněk O; Vondrášek J; Homola J; Malý J; Osička R; Sebo P; Malý P
    Proteins; 2012 Mar; 80(3):774-89. PubMed ID: 22113774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression.
    Meyer Zu Horste G; Wu C; Wang C; Cong L; Pawlak M; Lee Y; Elyaman W; Xiao S; Regev A; Kuchroo VK
    Cell Rep; 2016 Jul; 16(2):392-404. PubMed ID: 27346359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.
    Hummel TM; Ackfeld T; Schönberg M; Ciupka G; Schulz F; Oberdoerster A; Grötzinger J; Scheller J; Floss DM
    Mol Cell Biol; 2017 Sep; 37(17):. PubMed ID: 28630278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering site 3 interactions of interleukin 12 and interleukin 23 with their cognate murine and human receptors.
    Esch A; Masiarz A; Mossner S; Moll JM; Grötzinger J; Schröder J; Scheller J; Floss DM
    J Biol Chem; 2020 Jul; 295(30):10478-10492. PubMed ID: 32518162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.